Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
17.07. | ADDvise Group AB (publ): Interim report 2025, January 1-June 30 | 110 | GlobeNewswire (Europe) | In the second quarter of 2025, organic sales adjusted for currency effects increased, driven by steady demand for laboratory equipment and rental of equipment for clinical studies. Operating cash flow... ► Artikel lesen | |
11.07. | ADDVISE GROUP AB: ADDvise publishes prospectus and applies for admission to trading of bonds on Nasdaq Stockholm | 2 | Cision News | ||
09.07. | ADDVISE GROUP AB: Invitation to presentation of interim report April 1 - June 30, 2025 | 1 | Cision News | ||
ADDVISE GROUP Aktie jetzt für 0€ handeln | |||||
28.05. | ADDVISE GROUP AB: ADDvise announces that the conditions for early redemption of outstanding secured bonds have been fulfilled | 5 | Cision News | ||
26.05. | ADDvise Group AB (publ): ADDvise enters into facilities agreement with Nordea - reduces financial costs by approximately SEK 56 million per year | 1.532 | GlobeNewswire (Europe) | ADDvise Group AB (publ) has entered into a new secured facilities agreement with Nordea Bank Abp, filial i Sverige, with a total limit of SEK 450 million. As previously communicated, the company will... ► Artikel lesen | |
20.05. | ADDVISE GROUP AB: ADDvise announces the result of the tender offer regarding its outstanding senior secured bonds | 3 | Cision News | ||
19.05. | ADDVISE GROUP AB: ADDvise issues new SEK senior unsecured bonds | 2 | Cision News | ||
14.05. | ADDVISE GROUP AB: ADDvise intends to enter into a new facilities agreement and considers issuance of new SEK senior unsecured bonds as well as refinancing of outstanding SEK and USD senior secured bonds | 3 | Cision News | ||
12.05. | ADDvise Group AB (publ): Johan Irwe is appointed CFO, Staffan Torstensson (also CEO) assumes role as Head of the Healthcare segment, and Fredrik Mella departs | 119 | GlobeNewswire (Europe) | Since July 2024, Johan Irwe has served as interim CFO and has delivered strong results in the role. With his sharp analytical skills and dedicated leadership, Johan has created significant value for... ► Artikel lesen | |
12.05. | ADDvise Group AB (publ): Report from the annual general meeting of ADDvise Group AB (publ) on 12 May 2025 | 128 | GlobeNewswire (Europe) | ADDvise Group AB (publ), reg. no. 556363-2115, has today, on 12 May 2025, held its annual general meeting at the company's premises at Grev Turegatan 30 in Stockholm. At the meeting it was resolved... ► Artikel lesen | |
09.05. | ADDvise Group AB (publ): Interim report 2025, January 1-March 31 | 125 | GlobeNewswire (Europe) | In the first quarter of 2025, net revenue increased organically with continued good profitability, which shows stable demand in medical technology and laboratory solutions. Cash flow from operating... ► Artikel lesen | |
03.05. | ADDVISE GROUP AB: Invitation to presentation of interim report January 1 - March 31, 2025 | 2 | Cision News | ||
24.04. | New equity right for trading, ADDvise Group AB | 198 | GlobeNewswire | At the request of ADDvise Group AB, equity rights will be traded on First North Growth Market as from 25 April 2025.
Security name:
ADDvise Group AB TO 1 A
Short... ► Artikel lesen | |
09.04. | Notice to the annual general meeting of ADDvise Group AB (publ) | 1 | Cision News | ||
08.04. | ADDVISE GROUP AB: ADDvise raises approximately SEK 457 million in the rights issue | 3 | Cision News | ||
08.04. | ADDVISE GROUP AB: ADDvise Group publishes annual report and sustainability report for 2024 | 4 | Cision News | ||
07.04. | ADDVISE GROUP AB: ADDvise announces preliminary outcome of the rights issue | 2 | Cision News | ||
18.03. | XFRA CAPITAL ADJUSTMENT INFORMATION - 18.03.2025 | 617 | Xetra Newsboard | Das Instrument 0A3 NL0015000RT3 NEPI ROCKCASTLE EO -,01 EQUITY wird cum Kapitalmassnahme gehandelt am 18.03.2025 und ex Kapitalmassnahme am 19.03.2025 The instrument 0A3 NL0015000RT3 NEPI ROCKCASTLE... ► Artikel lesen | |
12.03. | ADDvise Group AB (publ): Report from the extra ordinary general meeting in ADDvise Group AB (publ) | 316 | GlobeNewswire (Europe) | ADDvise Group AB (publ), reg. no. 556363-2115 (the "Company"), has held an extraordinary general meeting on 12 March 2025. The general meeting resolved to amend the articles of association, approve... ► Artikel lesen | |
20.02. | ADDvise Group AB (publ): Year-end report 2024, January 1-December 31 | 191 | GlobeNewswire (Europe) | The fourth quarter of 2024 showed a turnaround in organic net revenue. In December alone, we are now back at positive organic growth of 4.8%. With new long-term financial targets, we are now taking... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
FRESENIUS MEDICAL CARE | 45,360 | -0,29 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
SIEMENS HEALTHINEERS | 47,090 | +0,38 % | SIEMENS HEALTHINEERS versucht die Börsenpräsenz zu erweitern | SIEMENS ist bereit, bis 51 % zu reduzieren. Das ergäbe ein Emissionsvolumen von geschätzt 17 bis 18 Mrd. € gegenüber dem aktuellen Stand. Aus München verlautet, dass es dafür kein Börsenkonsortium gibt... ► Artikel lesen | |
CARL ZEISS MEDITEC | 44,220 | +0,91 % | BERENBERG stuft CARL ZEISS MEDITEC AG auf 'Hold' | HAMBURG (dpa-AFX Analyser) - Die Privatbank Berenberg hat die Einstufung für Carl Zeiss Meditec mit einem Kursziel von 47 Euro auf "Hold" belassen. Finanzchef Justus Wehmer habe gute Gründe für mittelfristigen... ► Artikel lesen | |
UNITEDHEALTH | 305,85 | +1,34 % | HeraMED beschleunigt seinen KI-Fahrplan - Die nächste Phase der Frauengesundheit beginnt jetzt | ||
MEDTRONIC | 81,45 | -0,04 % | Dividendenbekanntmachungen (26.09.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ADF GROUP INC CA00089N1033 0,02 CAD 0,0123 EUR ALERUS FINANCIAL CORPORATION US01446U1034 0,21 USD 0,18 EUR ALICO INC US0162301040 0... ► Artikel lesen | |
INTUITIVE SURGICAL | 380,10 | +0,54 % | Opening Bell: Puma, Novo Nordisk, Droneshield, Rio Tinto, Robinhood, Intuitive Surgical | Alle Jahre wieder droht in den USA der Regierungsshutdown. Auch dieses Jahr. Demokraten und Republikaner haben sich noch nicht auf einen Haushalt geeinigt. Auswirkungen an der Börse waren noch nicht... ► Artikel lesen | |
THERMO FISHER | 445,60 | -0,54 % | Thermo Fisher Scientific Inc.: Thermo Fisher Scientific gibt Forschungskooperation mit AstraZeneca BioVentureHub bekannt | Der Geschäftsbereich PPD Clinical Research von Thermo Fisher Scientific, dem weltweit führenden Anbieter von wissenschaftlichen Dienstleistungen, hat heute eine neue Forschungs- und Entwicklungspartnerschaft... ► Artikel lesen | |
TELADOC HEALTH | 7,228 | -0,06 % | Down 96% From Its Highs, Is Teladoc a Hidden Bargain or a Value Trap? | ||
HIMS & HERS HEALTH | 49,970 | +1,15 % | Hims & Hers Health names new COO | ||
BICO GROUP | 1,923 | -0,31 % | BICO Group AB: Maria Rankka appointed Board Chair of BICO Group AB | The Board of Directors has with immediate effect among its members elected Maria Rankka to serve as Board Chair of BICO Group AB, until a new chair has been elected by the shareholders' meeting. Maria... ► Artikel lesen | |
EUROFINS SCIENTIFIC | 62,90 | 0,00 % | Eurofins Scientific: Director/PDMR Shareholding | Eurofins Scientific SE (EUFI.PA) has received various notifications of dealing from Persons Discharging Managerial Responsibilities ("PDMR"). The notification of Dealing Form for each PDMR can be... ► Artikel lesen | |
BECTON DICKINSON | 163,70 | +0,12 % | BD & Henry Ford Health Tie-Up to Enhance Community Pharmacy Experience | ||
ALIGN TECHNOLOGY | 110,70 | +0,82 % | Earnings Preview: What To Expect From Align Technology's Report | ||
NUGEN MEDICAL DEVICES | 0,034 | +5,66 % | Beaking News: NuGen Medical überwindet die "Master-Hürde"! | ||
INMODE | 13,090 | -0,83 % | InMode Ltd.: InMode Reports Second Quarter 2025 Financial Results: Quarterly Revenue of $95.6 Million, 80% Gross Margins | YOKNEAM, Israel, July 30, 2025 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, today announced... ► Artikel lesen |